(Q73538498)
Statements
Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinoma (English)
Strauss G
Lund B
Hansen M
scientific article published on 01 July 1997